- Home
- ACFN vs VNRX Comparison
ACFN vs VNRX Comparison
Compare ACFN & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACFN
- VNRX
- Stock Information
- Founded
- ACFN 1986
- VNRX N/A
- Country
- ACFN United States
- VNRX United States
- Employees
- ACFN N/A
- VNRX N/A
- Industry
- ACFN Military/Government/Technical
- VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- ACFN Consumer Discretionary
- VNRX Health Care
- Exchange
- ACFN Nasdaq
- VNRX Nasdaq
- Market Cap
- ACFN 76.5M
- VNRX 64.8M
- IPO Year
- ACFN N/A
- VNRX N/A
- Fundamental
- Price
- ACFN $29.28
- VNRX $0.64
- Analyst Decision
- ACFN
- VNRX Strong Buy
- Analyst Count
- ACFN 0
- VNRX 4
- Target Price
- ACFN N/A
- VNRX $3.50
- AVG Volume (30 Days)
- ACFN 21.8K
- VNRX 235.8K
- Earning Date
- ACFN 11-06-2025
- VNRX 11-13-2025
- Dividend Yield
- ACFN N/A
- VNRX N/A
- EPS Growth
- ACFN 1520.82
- VNRX N/A
- EPS
- ACFN 2.84
- VNRX N/A
- Revenue
- ACFN $13,202,000.00
- VNRX $1,319,252.00
- Revenue This Year
- ACFN N/A
- VNRX $399.39
- Revenue Next Year
- ACFN N/A
- VNRX $242.09
- P/E Ratio
- ACFN $9.98
- VNRX N/A
- Revenue Growth
- ACFN 50.98
- VNRX 35.10
- 52 Week Low
- ACFN $17.22
- VNRX $0.40
- 52 Week High
- ACFN $33.00
- VNRX $0.94
- Technical
- Relative Strength Index (RSI)
- ACFN N/A
- VNRX 50.15
- Support Level
- ACFN N/A
- VNRX $0.61
- Resistance Level
- ACFN N/A
- VNRX $0.74
- Average True Range (ATR)
- ACFN 0.00
- VNRX 0.04
- MACD
- ACFN 0.00
- VNRX 0.00
- Stochastic Oscillator
- ACFN 0.00
- VNRX 32.00
About ACFN Acorn Energy Inc. Common Stock
Acorn Energy Inc is a holding company that focuses on technology-driven solutions for energy infrastructure asset management. It operates through two segments namely, the PG segment and the CP segment. PG segment provides wireless remote monitoring and control systems and services for critical assets as well as Internet of Things applications which account for the majority of the revenue. CP segment is engaged in providing remote monitoring of cathodic protection systems on gas pipelines for gas utilities and pipeline companies.
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.